CCND1 and colorectal carcinoma: By inhibiting the expression of β-catenin protein and blocking the Wnt/β-catenin signaling pathway, BBR downregulates the expression of cell cycle protein Cyclin D1, resulting in the arrest of CRC cells in the G1 phase (Wu et al., 2012).